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Saliva is an interesting alternative diagnostic body fluid with several specific advantages
over blood. These include non-invasive and easy collection and related possibility to do
repeated sampling. One of the obstacles that hinders the wider use of saliva for diagnosis
and monitoring of systemic diseases is its composition, which is affected by local oral
status. However, this issue makes saliva very interesting for clinical biochemistry of oral
diseases. Periodontitis, caries, oral precancerosis, and other local oral pathologies are
associated with oxidative stress. Several markers of lipid peroxidation, protein oxidation
and DNA damage induced by reactive oxygen species can be measured in saliva.
Clinical studies have shown an association with oral pathologies at least for some of
the established salivary markers of oxidative stress. This association is currently limited
to the population level and none of the widely used markers can be applied for individual
diagnostics. Oxidative stress seems to be of local oral origin, but it is currently unclear
whether it is caused by an overproduction of reactive oxygen species due to inflammation
or by the lack of antioxidants. Interventional studies, both, in experimental animals as well
as humans indicate that antioxidant treatment could prevent or slow-down the progress
of periodontitis. This makes the potential clinical use of salivary markers of oxidative stress
even more attractive. This review summarizes basic information on the most commonly
used salivary markers of oxidative damage, antioxidant status, and carbonyl stress and
the studies analyzing these markers in patients with caries or periodontitis.
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INTRODUCTION
Saliva has become a popular diagnostic fluid for research and clinics in recent years. Its availability,
easy collection and possibility of repeated non-invasive sampling makes it ideal for screening,
diagnosis, or monitoring of many diseases. However, many technical issues have to be overcome
and sensitivity as well as specificity have to be increased before routine clinical use. Several articles
have been published dealing with saliva and its diagnostic potential in the past (Kaufman and
Lamster, 2002; Chiappin et al., 2007; Lee and Wong, 2009). One review article has summarized
the literature on oxidative stress in oral cavity-related pathologies. However, the review was not
specifically oriented on oxidative stress in saliva (Iannitti et al., 2012). One critical review on this
topic has been published recently, but was mainly focused on the methodology and statistical
analysis used in the published studies (Wang et al., 2015a).
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Periodontitis and dental caries represent the most common
oral diseases. Very often, low adherence to oral hygiene and
follow-up treatment lead to worsening of the disease and
subsequently to loss of teeth (Renz et al., 2007). A non-
invasive approach to diagnose and to monitor the progress of
periodontitis and dental caries is needed that would improve
the adherence and the overall therapeutic outcome. This review
therefore aims to summarize the current findings in the
research of oxidative stress analyzed in saliva in relation to oral
diseases.
SALIVA AS A DIAGNOSTIC FLUID
Saliva is produced by secretion from the three major salivary
glands (the parotid, submandibular, and sublingual glands) and
numerous minor salivary glands. The collected whole saliva is
a more complex mixture of fluids including gingival cevicular
fluid, as well as oral, nasal, and mucosal transudate (Humphrey
and Williamson, 2001). Additionally, oral bacteria and their
metabolites, desquamated epithelial and blood cells, food debris
and various chemical products are present in the saliva (de
Almeida Pdel et al., 2008). Daily saliva production is estimated to
be between 0.75 and 1.5 L in healthy adults. Salivary secretion is
under both neural and hormonal control (Proctor and Carpenter,
2007). Nevertheless, salivary flow rate can be affected by various
factors, such as circadian cycle, age, hydratation, chewing, oral
hygiene, physical exercise, and others (Dawes, 1972; Chicharro
et al., 1998; Chiappin et al., 2007; de Almeida Pdel et al., 2008).
Physiologial pH of saliva is between 6.2 and 7.4 (Schipper
et al., 2007). From biochemical point of view, saliva is an aqueous
solution (more than 99% is water) containing numerous organic
and anorganic molecules (Greabu et al., 2009; Lima et al., 2010).
Saliva may reflect the current physiological condition of the
body and therefore is often called “the mirror of health of
the organism” (Farnaud et al., 2010; Yoshizawa et al., 2013).
The exchange between plasma and saliva takes place in the
salivary ducts, which are separated from the circulation system
as a thin layer of epithelial cells. The exchange includes active
transport, diffusion across the cell membrane by passive diffusion
directed by the concentration gradient (Lee and Wong, 2009).
In patients suffering from oral diseases such as periodontitis
there is a higher probability of blood leakage into saliva. This
leads to the occurrence of blood components in saliva (Schwartz
and Granger, 2004). This could interfere with various analytical
methods and, thus, hinder the diagnostic use of saliva. However,
at least for some of themost commonly usedmarkers of oxidative
stress we have found that blood contamination up to 1% does
not affect even spectrophotometric methods and samples with
higher blood concentrations can easily be excluded (Kamodyová
et al., 2015). Since saliva represents a rapidly changing dynamic
environment, it can potentially be used for long-termmonitoring
of oral diseases. In addition, new high-throughput approaches
are being introduced for fast, reliable, and reproducible salivary
diagnostic tests. Research on saliva cannot escape the current
technological revolution. The whole salivary metabolome has
already been described using several methodological approaches
(Dame et al., 2015).
Similarly to plasma and tissues, free radicals and reactive
oxygen/nitrogen species (ROS/RNS) in saliva play an important
role in redox-dependent signaling and are necessary for
physiological functions (Valko et al., 2007). On the other hand,
excessive production of free radicals can lead to oxidative stress
(Sies, 1997). Redox balance is than shifted in favor of oxidants.
ROS/RNS can induce oxidative damage to cellular components
with serious pathophysiological consequences (Devasagayam
et al., 2004). On contrary, various antioxidant mechanisms
are present in saliva including low molecular antioxidants—
glutathione, ascorbic, and uric acid as well as melatonin (Moore
et al., 1994; Balaji et al., 2015). Antioxidant enzymes such as
superoxide dismutase, catalase, and glutathione peroxidase are
present in saliva (Battino et al., 2002). Their function is to
protect oral cavity against the negative effects of endogenous
and exogenous ROS/RNS. Additionally, membrane and DNA
repair enzymes as well as proteases that degrade oxidatively
modified proteins reduce the consequences of oxidative damage
in saliva. Saliva is intended to be the first line defense against
free radicals (Amerongen and Veerman, 2002; Battino et al.,
2002). The dysbalance between the production of free radicals
and antioxidant status in favor of oxidants is called oxidative
stress. Oxidative stress has been implicated in the etiology and
pathogenesis of several oral diseases including dental caries and
periodontitis (Iannitti et al., 2012). This has already been shown
by expression analysis of antioxidant genes in periodontitis
patients (Zeidan-Chulia et al., 2013). Although it is not clear
whether it is a cause or consequence of the disease process.
SALIVARY BIOMARKERS OF OXIDATIVE,
CARBONYL STRESS, AND ANTIOXIDANT
STATUS
Biomarkers are any characteristics which can be objectively
measured and allow to predict the diagnosis, onset, or
progression of a disease (Maiese et al., 2010). Optimal biomarkers
for diagnostics of oxidative stress related diseases should be
stable, accumulated in detectable concentrations, reflect specific
oxidation pathways, and correlate with disease severity (Dalle-
Donne et al., 2006). Considering free radicals are highly reactive
and have a short half-life, the products formed from the reaction
of ROS/RNS with cellular macromolecules are used preferentially
as biomarkers of oxidative damage (Palmieri and Sblendorio,
2007a,b). Lipid peroxidation products, oxidized proteins, and
products of DNA oxidation and fragmentation—are used for
the assessment of oxidative stress. Measurement of various
antioxidants or total antioxidant status represent another option
of analyzing the redox status. Nevertheless, the use of a panel
of biomarkers instead of a single parameter provides more
informative results, reduces false positive and false negative
results and enables a better understanding of the underlying
pathomechanisms. The recent technological advances enabled
the progress in systems biology and saliva research is moving into
the omics world. Also using the metabolomic approach markers
of oxidative stress were found to be among the discriminative
between patients with periodontitis and healthy controls (Barnes
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et al., 2014). This confirms that the research of salivary markers
of oxidative stress is worth the effort.
Lipid Peroxidation
Lipid peroxidation is a reaction of lipids such as polyunsaturated
fatty acids with ROS/RNS leading to formation of lipid
hydroperoxides. This is accompanied by a complex process of
degradation and decomposition reactions of hydroperoxides,
whereby a wide range of products is formed (Dotan et al.,
2004; Palmieri and Sblendorio, 2007a). The endproducts of lipid
peroxidation aremore stable than free radicals. Additionally, they
can further react with other macromolecules, including DNA,
proteins and phospholipids, far from the site of their production
(Dalle-Donne et al., 2006). The most studied marker of lipid
peroxidation is malondialdehyde (MDA). MDA is produced
from fatty acids with two or more methylene-interrupted double
bonds (Ayala et al., 2014). Standard method used for MDA
detection is the spectrophotometric assay developed by Yagi,
which is based on the reaction with thiobarbituric acid in acidic
environment. It is also referred to as thiobarbituric acid reacting
substances (TBARS) assay (Yagi, 1976). This assay is not specific
for MDA and other aldehydes may react with thiobarbituric acid
to produce a compound that absorbs wavelengths in the same
range as MDA. Liquid chromatography or mass spectroscopy
methods were reported as more reliable and specific for the
measurement of MDA (Akalin et al., 2007), but the TBARS assay
still represents a commonly used, cheap and high throughput
method for the quantitative analysis of lipid peroxidation.
Another marker produced during lipid peroxidation is 4-
hydroxy-2-nonenal that is generated by free radical attack on
ω—6 polyunsaturated fatty acids (arachidonic, linoleic, and
linolenic acids) (Sayre et al., 2006). Isoprostanes are unique
products of lipid peroxidation of arachidonic acid and are
considered to be reliable biomarkers of free radical mediated
lipid peroxidation in vivo (Devasagayam et al., 2004; Spickett,
2013). Conjugated dienes are another option for analysis of lipid
peroxidation. Unfortunately, few studies dealt with several of
these markers, so the data about their usefulness for oral disease
monitoring are limited.
Protein Oxidation
Proteins are major targets for ROS/RNS because they are highly
abundant and are responsible for most functional processes in
the cell (Dalle-Donne et al., 2003). The oxidation of proteins
can take place at the level of single amino acid residues, it can
lead to fragmentation of polypeptide chains or to covalent cross-
linking of two amino acids either of the same or of two different
proteins (Shacter, 2000). Oxidized proteins are either catabolized
in proteosomal and lysosomal pathways or aggregated and
accumulated in cellular compartments (Stadtman and Berlett,
1998).
Widespread methods for assessment of protein oxidation are
the measurement of carbonyl groups by specific antibodies in
ELISA orWestern blot and by spectrophotometric assay based on
dinitrophenylhydrazine derivitization (Dalle-Donne et al., 2003;
Cabiscol et al., 2014). The advantages of protein carbonyls as
a marker in comparison to lipid peroxidation products include
early production and greater stability of oxidized proteins.
Nonetheless, the production of protein carbonyl groups can be
induced by almost all types of ROS and so, the protein carbonyl
assay does not provide information about the source of oxidative
stress. A major factors influencing most biomarkers of oxidative
stress and protein carbonyl especially is aging. The relatively high
correlation coefficients between salivary carbonyls and age led to
a suggestion of protein carbonyls as an alternative biomarker of
aging (Wang et al., 2015b).
Advanced oxidation protein products (AOPP) represent
a sensitive biomarker of protein oxidation, especially due
to neutrophil activation and the enzymatic activity of
myeloperoxidase (Witko-Sarsat et al., 1996). AOPP were
formerly thought to be a novel uremic toxin, reflecting highly
oxidized protein status, but oxidized fibrinogen was found
to be the major molecule responsible for the increase of the
AOPP concentration (Selmeci, 2011). This should be taken into
account, when interpreting the results.
Oxidative DNA Damage
The ROS/RNS react with DNA inducing damage to purine
and pyrimidine bases and also the deoxyribose backbone
(Halliwell, 2000). Pyrimidine damage products include thymine
glycol, uracil glycol, urea residue, 5-hydroxydeoxyuridine,
5-hydroxydeoxycytidine, hydantoin, and others. Purine
damage products are 8-hydroxydeoxyguanosine (8-OHdG),
8-hydroxydeoxyadenosine, formamidopyrimidines, and other
less characterized purine oxidative products (Cadet et al., 2003).
Measurement of 8-OHdG has been used to assess “whole-
body” oxidative DNA damage using various analytical methods
(Henderson et al., 2010). The issue with measuring 8-OHdG
concentration is that 8-OHdG may not truly reflect oxidative
damage to DNA. 8-OHdG can arise not just from removal of
oxidized guanine residues from DNA by repair processes but
also from degradation of oxidized dGTP in the DNA precursor
pool. Recently published data, however, show that there is a
clear strong association between the salivary concentrations of 8-
OHdG and the clinical indices of periodontal status (Villa-Correa
et al., 2015).
Carbonyl Stress
Carbohydrates such as glucose react non-enzymatically with the
free amino groups of proteins and proceeds from reversible Schiff
base adducts to more stable Amadori products. Some Amadori
products are further converted to advanced glycation end
products (AGEs) through a series of chemical rearrangements,
dehydration, and fragmentation reactions (Ott et al., 2014). In
addition to endogenously formed, AGEs can also be derived
from exogenous sources such as smoking and food (Singh
et al., 2001; Nass et al., 2007). Carbonyl precursors can
form oxidative AGEs such as Nε-(carboxymethyl)lysine and
pentosidine or non-oxidative AGEs such as 3-deoxyglucosone
or methylglyoxal (Singh et al., 2001). Pentosidine is derived
exclusively from carbohydrate-derived carbonyl group and
protein amino group while Nε-(carboxymethyl)lysine originates
not only from carbohydrates but also from autooxidation of lipids
and amino acids (Zoccali et al., 2000). Nε-(carboxymethyl)lysine
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 3 October 2015 | Volume 5 | Article 73
Tóthová et al. Saliva and oxidative stress
therefore serves as a general biomarker of oxidative stress, mostly
assessed by ELISA or Western blotting.
AGEs are a heterogeneous group of protein-bound
moieties and are characterized by browning, fluorescence,
and crosslinking. Their determination is based on detection of
specific fluorescence of AGEs at 370 nm excitation and 440 nm
emission (Münch et al., 1997). Other methods such as ELISA,
polyclonal antibodies, HPLC, or immunohistochemistry have
been also applied to determine specific AGEs (Ahmed et al.,
2002; Lapolla et al., 2005; Schmitt et al., 2005). Measurement
of non-enzymatically glycated total proteins is referred to as
fructosamine assay (Armbruster, 1987). Glucose bound to
protein by aldimine linkage undergoes Amadori rearrangement
through nonenzymatic glycation to the ketoamine (generically
termed fructosamine). Fructosamine spectrophotometric assay
is a simple test based upon the property of fructosamines to act
as reducing agents in alkaline solution (San-Gil et al., 1985).
Nitrosative Stress
Similarly to oxidative stress, nitrosative stress is characterized
as the imbalance between reactive nitrogen species and the
antioxidants in favor of pro-oxidant RNS. Immoderate/excessive
production of nitric oxide (NO) have detrimental effects on
biomacromolecules. Due to its highly reactive nature, NO
reacts with other reactive species (i.e., superoxide) leading to
formation of more reactive compounds resulting in cytotoxic
effects (Eiserich et al., 1998). On the other hand, NO can
be oxidized to nitrite (NO−2 ) and subsequently oxidized to
nitrate (NO−3 ). Therefore, the total concentrations of nitrite
and nitrate are summed to adequately determine complex NO
production. Salivary nitrates/nitrites are measured by Gries
colorimetric assay (Andrukhov et al., 2013). Salivary NO and its
derivates have been studied in relation to plasma NO, endothelial
function, dietary intake of NO donors etc. However, most of the
analyzed correlations were not significant (Clodfelter et al., 2015).
Although the test was originally developed to help cardiologists,
it is clear that the salivary NO concentrations are most affected by
local oral processes and could, thus, be more usable for dentists
and their patients.
Antioxidant Status
The measurement of individual antioxidants in biological
samples is time consuming, labor-intensive, costly and requires
complicated chemical techniques. In addition, the antioxidant
effects are additive and therefore total antioxidant capacity of
samples is preferentially measured (Erel, 2004). Antioxidant
capacity assays can be divided into assays involving oxidants
that are not necessarily pro-oxidants and assays involving
oxidants that are pro-oxidants (Prior and Cao, 1999). To
the first group of assays belong for example the ferric
reducing/antioxidant power (FRAP) assay and the Trolox
equivalent antioxidant capacity. The second group of assays
includes total radical trapping parameter assay, luminol-
based assays, dichlorofluorescin-diacetate based assay, crocin
based assays, phycoerythrin based assays, and oxygen radical
absorbance capacity assay (Prior and Cao, 1999). The increased
antioxidant capacity can be a consequence of an adaptive
response to a long term increased oxidative stress. On the other
hand, the decrease in antioxidant capacity is not necessarily an
undesirable condition when the production of reactive species
decreases. The results of antioxidant assays should therefore be
interpreted with caution.
SALIVARY OXIDATIVE STRESS IN ORAL
DISEASES
Dental Caries
Dental caries is the most prevalent oral disease worldwide
affecting both, children and adults and leading to pain and
tooth loss. Systematic review dealing with the pathogenesis,
epidemiology, diagnosis, and treatment of dental caries was
published previously (Selwitz et al., 2007). Dental caries is
a multifactorial inflammatory disease. However, the primary
trigger is usually acidic by-products formed during bacterial
fermentation of carbohydrates (Selwitz et al., 2007). In a recent
review, the concept of inflammatory response in dentin, tightly
connected with oxidative stress leading to the destruction of
dental hard tissues is discussed (Southward, 2011). It was shown
that dentinal fluid movement is inhibited by high sucrose levels
causing down-regulation of parotid hormone from hypothalamic
signaling. The consequence is that teeth become susceptible to
bacterial acids (Leonora et al., 1993). The important role of
ROS and antioxidants on the regulation of parotid hormone was
hypothesized in a review dealing with the systemic theory of
dental caries (Southward, 2011).
The importance of saliva in terms of salivary flow and
antibacterial protection is generally accepted for the pathogenesis
of dental caries (Lenander-Lumikari and Loimaranta, 2000;
Stookey, 2008). The role of oxidative stress in dental caries is
less clear, but it is the focus of intense research. Nine studies
performed on children and four studies performed on adult
subjects analyzing salivary oxidative stress in relation to dental
caries are summarized in Table 1. Most research dealing with
salivary oxidative stress in relation to dental caries is analyzing
the antioxidant properties of saliva. Tulunoglu et al. have
measured the antioxidant capacity of saliva in 80 children with
and without caries activity (Tulunoglu et al., 2006). Children
were divided into 8 groups according to age, gender, and caries
activity. Non-significantly higher TAC was observed in caries
active children and this observation was attributed to higher
protein concentrations in caries active children. The exception
was the group of 11–15 years old girls, where total protein and
antioxidant capacity were lower in caries active group (Tulunoglu
et al., 2006). In a very similar study TAC was analyzed in 120
children with and without caries activity (Preethi et al., 2010).
Similarly to the previous study, children were divided into 8
groups. TAC was significantly higher in caries active girls and
also boys in comparison to age matched control subjects. Total
proteins were significantly higher in caries active in comparison
to caries free children (Preethi et al., 2010; Dodwad et al., 2011).
In the next study, relationship between the total antioxidant
capacity of saliva and dental caries was assessed in deciduous
and permanent teeth of Saharan children (Uberos et al., 2008).
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)
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 5 October 2015 | Volume 5 | Article 73
Tóthová et al. Saliva and oxidative stress
T
A
B
L
E
1
|
C
o
n
ti
n
u
e
d
P
a
ti
e
n
ts
A
n
a
ly
z
e
d
m
a
rk
e
rs
a
n
d
m
e
th
o
d
s
D
e
te
c
te
d
c
o
n
c
e
n
tr
a
ti
o
n
s
R
e
s
u
lt
s
R
e
f.
C
a
rie
s
fr
e
e
g
ro
u
p
,
TA
C
(7
.3
±
4
.3
1
/I
C
5
0
);
G
ro
u
p
w
ith
c
a
rie
s
a
c
tiv
ity
1
–2
,
TA
C
(7
.2
±
4
.2
1
/I
C
5
0
);
G
ro
u
p
w
ith
c
a
rie
s
a
c
tiv
ity
3
–4
,
TA
C
(8
.7
±
4
.7
1
/I
C
5
0
);
G
ro
u
p
w
ith
c
a
rie
s
a
c
tiv
ity
5
+
,
TA
C
(1
1
.5
±
1
2
.4
1
/I
C
5
0
)
1
0
0
c
h
ild
re
n
,
4
g
ro
u
p
s—
w
ith
e
a
rly
c
h
ild
h
o
o
d
c
a
rie
s
a
n
d
c
o
n
tr
o
ls
(b
e
lo
w
7
1
m
o
n
th
s)
,
w
ith
ra
m
p
a
n
t
c
a
rie
s
a
n
d
c
o
n
tr
o
ls
(6
–1
2
ye
a
rs
)
TA
C
(S
P
H
)
E
a
rly
c
h
ild
h
o
o
d
c
a
rie
s
TA
C
(2
5
.5
8
±
1
2
.1
2
m
m
o
l/
l);
E
a
rly
c
h
ild
h
o
o
d
c
a
rie
s
fr
e
e
c
o
n
tr
o
ls
,
TA
C
(1
4
.1
5
±
4
.2
4
m
m
o
l/
l)
R
a
m
p
a
n
t
c
a
rie
s,
TA
C
(4
6
.1
2
±
0
.9
9
m
m
o
l/
l);
R
a
m
p
a
n
t
c
a
rie
s
fr
e
e
c
o
n
tr
o
ls
,
TA
C
(2
2
.9
6
±
4
.7
6
m
m
o
l/
l)
↑
TA
C
in
c
h
ild
re
n
w
ith
c
a
rie
s
(p
<
0
.0
0
1
),
TA
C
w
a
s
in
c
re
a
se
d
w
ith
th
e
a
g
e
o
f
th
e
c
h
ild
re
n
(p
<
0
.0
0
1
)
H
e
g
d
e
e
t
a
l.,
2
0
0
9
8
0
c
h
ild
re
n
,
(a
g
e
d
3
–5
ye
a
rs
),
2
g
ro
u
p
s—
w
ith
se
ve
re
e
a
rly
c
h
ild
h
o
o
d
c
a
rie
s
a
n
d
c
o
n
tr
o
ls
(n
=
4
0
/p
e
r
g
ro
u
p
)
F
R
A
P
(S
P
H
)
N
/A
↑
F
R
A
P
in
c
h
ild
re
n
w
ith
se
ve
re
e
a
rly
c
h
ild
h
o
o
d
c
a
rie
s
(p
=
0
.0
2
5
)
M
a
h
jo
u
b
e
t
a
l.,
2
0
1
4
5
0
c
h
ild
re
n
,
(a
g
e
d
3
–5
ye
a
rs
),
2
g
ro
u
p
s—
w
ith
se
ve
re
e
a
rly
c
h
ild
h
o
o
d
c
a
rie
s
a
n
d
c
o
n
tr
o
ls
(n
=
2
5
/p
e
r
g
ro
u
p
)
TA
C
(S
P
H
)
S
e
ve
re
e
a
rly
c
a
rie
s,
TA
C
(1
.8
2
±
0
.1
9
m
m
o
l/
ls
a
liv
a
);
C
o
n
tr
o
lg
ro
u
p
TA
C
(1
.0
8
±
0
.1
7
m
m
o
l/
ls
a
liv
a
)
↑
TA
C
in
c
h
ild
re
n
w
ith
se
ve
re
e
a
rly
c
h
ild
h
o
o
d
c
a
rie
s
(p
<
0
.0
0
0
1
)
M
u
c
h
a
n
d
ie
t
a
l.,
2
0
1
5
1
0
0
h
e
a
lth
y
h
ig
h
sc
h
o
o
ls
tu
d
e
n
ts
(a
g
e
1
5
–1
7
ye
a
rs
),
4
g
ro
u
p
s
a
c
c
o
rd
in
g
to
g
e
n
d
e
r
a
n
d
c
a
rie
s
a
c
tiv
ity
.
(C
a
rie
s
a
c
tiv
e
w
a
s
c
o
n
fir
m
e
d
w
h
e
n
vo
lu
n
te
e
r
h
a
d
a
t
le
a
st
5
c
a
rie
s
su
rf
a
c
e
s)
TA
C
(S
P
H
)
B
o
ys
,
c
a
rie
s
a
c
tiv
e
TA
C
(5
9
.7
2
±
1
2
.1
5
);
B
o
ys
,
c
a
rie
s
fr
e
e
TA
C
(4
1
.3
2
±
9
.9
2
);
G
irl
s,
c
a
rie
s
a
c
tiv
e
TA
C
(4
0
.9
5
±
1
5
.4
8
);
G
irl
s,
c
a
rie
s
fr
e
e
TA
C
(4
0
.1
6
±
1
1
.8
8
)
↑
TA
C
in
c
a
rie
s
a
c
tiv
e
m
a
le
s
w
h
e
n
c
o
m
p
a
re
d
to
c
a
rie
s
fr
e
e
m
a
le
s
(p
<
0
.0
0
1
).
In
fe
m
a
le
s,
n
o
d
iff
e
re
n
c
e
in
TA
C
(p
<
0
.8
4
).
↑
TA
C
in
m
a
le
s
w
h
e
n
c
o
m
p
a
re
d
to
fe
m
a
le
s
(p
<
0
.0
0
1
)
A
h
m
a
d
i-
M
o
ta
m
a
ye
l
e
t
a
l.,
2
0
1
3
2
1
a
d
u
lt
p
a
tie
n
ts
w
ith
c
a
rie
s,
1
6
c
o
n
tr
o
ls
G
S
H
(S
P
H
),
L
P
O
(S
P
H
)
C
a
rie
s
g
ro
u
p
,
G
S
H
(1
.6
±
0
.7
5
m
g
/g
p
ro
te
in
),
L
P
O
(0
.3
±
0
.1
5
µ
m
o
lM
D
A
/g
p
ro
te
in
);
↓
G
S
H
in
c
a
rie
s
g
ro
u
p
(p
<
0
.0
5
),
n
e
g
a
tiv
e
c
o
rr
e
la
tio
n
b
e
tw
e
e
n
D
M
F
T
a
n
d
G
S
H
(p
<
0
.0
5
)
O
zt
ü
rk
e
t
a
l.,
2
0
0
8
C
o
n
tr
o
lg
ro
u
p
,
G
S
H
(2
.2
±
0
.8
m
g
/g
p
ro
te
in
),
L
P
O
(0
.3
3
±
0
.2
8
µ
m
o
lM
D
A
/g
p
ro
te
in
)
6
7
a
d
u
lt
p
a
tie
n
ts
w
ith
d
e
n
ta
lc
a
rie
s,
5
0
c
o
n
tr
o
ls
T
B
A
R
S
(S
P
H
)
F
e
m
a
le
s,
c
a
rie
s
fr
e
e
,
M
D
A
(3
.2
4
±
0
.5
4
n
g
/m
L
);
↑
M
D
A
in
c
a
rie
s
a
c
tiv
e
p
a
tie
n
ts
(p
=
n
s)
R
a
ie
t
a
l.,
2
0
0
6
M
a
le
s,
c
a
rie
s
fr
e
e
,
M
D
A
(3
.3
8
±
0
.3
3
n
g
/m
L
);
F
e
m
a
le
s,
c
a
rie
s
a
c
tiv
e
,
M
D
A
(3
.3
6
±
1
.4
2
n
g
/m
L
);
M
a
le
s,
c
a
rie
s
a
c
tiv
e
,
M
D
A
(3
.4
2
±
0
.2
2
n
g
/m
L
)
1
0
0
a
d
u
lt
p
a
tie
n
ts
,
4
g
ro
u
p
s
(n
=
2
5
/p
e
r
g
ro
u
p
)—
c
o
n
tr
o
lg
ro
u
p
,
g
ro
u
p
I(
D
M
F
T
<
3
),
g
ro
u
p
II
(D
M
F
T
<
1
0
),
g
ro
u
p
III
(D
M
F
T
>
1
0
)
TA
C
(S
P
H
)
C
o
n
tr
o
lg
ro
u
p
,
TA
C
(0
.3
4
±
0
.1
3
µ
m
o
l/
L
);
G
ro
u
p
I,
TA
C
(0
.4
4
±
0
.1
3
µ
m
o
l/
L
);
G
ro
u
p
II,
TA
C
(0
.5
6
±
0
.2
6
µ
m
o
l/
L
);
G
ro
u
p
III
,
TA
C
(0
.5
9
±
0
.1
8
µ
m
o
l/
L
)
↑
TA
C
w
a
s
o
b
se
rv
e
d
in
g
ro
u
p
s
w
ith
h
ig
h
e
r
D
M
F
T
sc
o
re
(p
<
0
.0
0
1
)
H
e
g
d
e
e
t
a
l.,
2
0
1
3
T
A
C
,
to
ta
la
n
ti
o
xi
d
a
n
t
c
a
p
a
c
it
y;
A
O
P
P,
a
d
va
n
c
e
d
o
xi
d
a
ti
o
n
p
ro
te
in
p
ro
d
u
c
ts
;
T
B
A
R
S
,
th
io
b
a
rb
it
u
ri
c
a
c
id
re
a
c
ti
n
g
s
u
b
s
ta
n
c
e
s
;
A
G
E
S
,
a
d
va
n
c
e
d
g
ly
c
a
ti
o
n
e
n
d
p
ro
d
u
c
ts
;
F
R
A
P,
fe
rr
ic
re
d
u
c
in
g
a
n
ti
o
xi
d
a
n
t
p
o
w
e
r;
G
S
H
,
re
d
u
c
e
d
g
lu
ta
th
io
n
e
;
L
P
O
,
lip
id
p
e
ro
xi
d
a
ti
o
n
;
S
P
H
,
s
p
e
c
tr
o
p
h
o
to
m
e
tr
y;
S
F
L
,
s
p
e
c
tr
o
flu
o
ro
m
e
tr
y;
#
d
e
n
o
te
s
le
ve
ls
e
s
ti
m
a
te
d
fr
o
m
g
ra
p
h
.
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 6 October 2015 | Volume 5 | Article 73
Tóthová et al. Saliva and oxidative stress
This study is one of the largest focusing on caries and salivary
markers of antioxidant status. The authors have found a higher
TAC in deciduous teeth of caries active patients than of caries free
patients. Linear association was observed between the number of
deciduous, but not permanent teeth affected by caries and TAC
(Uberos et al., 2008). Hegde et al. and Kumar et al. have found
that TAC in children with early childhood caries is higher than in
controls with age being a significant confounding factor (Hegde
et al., 2009; Kumar et al., 2011). The results were confirmed in
another study in very young children (Muchandi et al., 2015).
In a case-control study performed on 80 children FRAP as a
measure of antioxidant status higher in children with caries
(Mahjoub et al., 2014). Similarly, TAC was higher in adolescent
males with active caries (Ahmadi-Motamayel et al., 2013). The
reason for the higher antioxidant status in all studies remains
unclear. A likely mechanism could include the response of the
host to an infection/inflammation. All above mentioned studies
had a case-control design. The study conducted by Tóthová et al.
had a cross-sectional design with 82 children (4–18 years old)
(Tóthová et al., 2013a). In this study beyond salivary antioxidant
status (TAC and FRAP) also oxidative stress markers were
analyzed in relation to caries index in children. These included
TBARS, AOPP, and AGEs. Multivariate analysis showed that
salivary AOPP are related to caries index (eta 8.6%), however
ANOVA revealed no significant association between CI and
AOPP (Tóthová et al., 2013a).
The study conducted in adults by Öztürk et al. was the first
study analyzing the role of salivary glutathione (GSH) as an
antioxidant in relation to dental caries (Oztürk et al., 2008).
Significantly lower GSH concentrations were detected in adults
with caries compared to subjects without caries and a negative
correlation was observed between clinical indices and GSH.
In this study no difference in lipid peroxidation was observed
between subjects with andwithout caries (Oztürk et al., 2008). Rai
et al. have analyzed TBARS in the saliva of caries active patients.
Higher lipid peroxidation was detected in caries active patients
than in control patients (Rai et al., 2006). Ahmadi-Motamayel
et al. have analyzed TAC in caries active and caries free students
(Ahmadi-Motamayel et al., 2013). In this study higher TAC was
found in the group with caries, especially in males. Subtle gender
differences were indicated by lower TAC in caries active females
than in caries active males (Ahmadi-Motamayel et al., 2013). The
association between TAC and caries severity was confirmed later
(Hegde et al., 2013).
Most of the studies found that the antioxidant status is higher
in caries active probands. As emphasized by Prior and Cao,
an increased antioxidant capacity may be an adaptive response
to increased oxidative stress (Prior and Cao, 1999). On the
other hand, decreased GSH levels could suggest a tendency
to decreased antioxidant status (Oztürk et al., 2008). The
contradictory findings could be partially explained by temporal
differences. As an acute effect the antioxidant status could be
increased, but long term effects could contribute to consumption
of antioxidants. It is clear that a panel of oxidative stress and
antioxidant status markers is needed to interpret the role of
oxidative stress in disease pathogenesis and progression (Prior
and Cao, 1999). The only study in which a panel of salivary
oxidative stress and antioxidant status markers was analyzed
was the study conducted in children by Tóthová et al. (2013a).
Although association studies have a clear outcome, there is a
lack of mechanistic studies on the role of ROS or oxidative
damage in saliva in relation to dental caries. Based on previous
studies, it appears that there is no association between salivary
lipid peroxidation and dental caries (Rai et al., 2006; Oztürk
et al., 2008; Tóthová et al., 2013a). However, to interpret the
relationship between dental caries and oxidative stress in saliva
it is necessary to perform more carefully designed studies
incorporating whole palette of oxidative stress and antioxidant
status markers and, more importantly, experimental animal
studies focusing on the underlying mechanism associated with
ROS/RNS.
Periodontal Diseases
Periodontitis is affecting 11% of the global population (Marcenes
et al., 2013). Its incidence varies in different populations and
depends on oral hygiene and socio-economic status (Rylev and
Kilian, 2008). Periodontitis is a chronic infectious disease of the
supporting tissues of teeth and can lead to loss of connective
tissue attachment, alveolar bone resorption, increased mobility
of teeth and subsequent teeth loss. The etiology and pathogenesis
of periodontitis is multifactorial and includes periodontal
pathogens, biofilm formation, host immune response, and
genetic risk factors (Laine et al., 2012).
The production of proteolytic enzymes and the respiratory
burst of neutrophils mediated by enzymes such as NADPH
oxidase andmyeloperoxidase lead to generation of ROS/RNS and
induce oxidative stress (Nizam et al., 2014; Syndergaard et al.,
2014). These mechanisms play a key role in the pathogenesis
of periodontitis as summarized by Chapple and Matthews in
their comprehensive review (Chapple and Matthews, 2007).
Salivary myeloperoxidase was found to be higher in periodontitis
patients (Meschiari et al., 2013). The most common parameters
of oxidative damage in association to periodontal diseases are
markers of lipid peroxidation. Tsai et al. found higher lipid
peroxidation in saliva of chronic periodontitis patients in a case-
control study. An important secondary finding was that lipid
peroxidation in saliva and gingival crevicular fluid correlated
positively (Tsai et al., 2005). The association between periodontal
status and salivary TBARS was confirmed in our large cross-
sectional study with 217 patients (Celec et al., 2005). In a
preliminary part of this study we found no correlation between
salivary and plasma TBARS and, thus, local intraoral production
of TBARS was hypothesized (Celec et al., 2005). Other studies
confirmed higher lipid peroxidation in patients with severe but
not moderate periodontitis (Mashayekhi et al., 2005; Khalili
and Biloklytska, 2008) suggesting that the association between
periodontitis and salivary TBARSmight not be linear (Dalai et al.,
2013). More recently, male patients, but not women with chronic
periodontitis showed higher concentrations of salivary TBARS
compared to healthy controls (Banasová et al., 2015). This could
be due to changes in the changes in salivary cytokines during
the menstrual cycle (Becerik et al., 2010). However, menstrual
cycle related changes in salivary TAC concentrations have also
been described with lower TAC during the ovulation period
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(Kawamoto et al., 2012). In line with these findings are the results
of unique study on pregnant women. It has been shown that
pregnancy has an effect on several markers of oxidative stress
and, more importantly, that the association between TBARS and
periodontal status found in the general population could not be
proved for pregnant women or women who gave birth recently
(Gümüs et al., 2015). This is very likely related to the hormonal
changes in pregnancy that have major impact on oral health and
local immune status (Gürsoy et al., 2014).
MDA is the most studied product of lipid peroxidation.
However, MDA is only one of many products formed during
lipid peroxidation. TOS assay developed by Erel provides a
possibility to measure additive effects of oxidants (Erel, 2005).
Akalin et al. utilized TOS assay to measure oxidants in saliva of
chronic periodontitis patients. Higher MDA and TOS levels were
observed in saliva and also gingival crevicular fluid of chronic
periodontitis patients (Akalin et al., 2007). The importance of
lipid peroxidation in saliva was confirmed in another showing
that the lipid peroxidation in saliva of patients who smoke and
suffer from periodontitis is higher when compared to healthy
probands (Guentsch et al., 2008). Increased oxidative damage
of DNA, lipids and proteins were observed in periodontitis
patients in a cross-sectional study (Su et al., 2009). In our cross-
sectional study with more than 200 participants salivary TBARS,
AOPP, AGEs, and TAC were assessed in relation to dental health,
gender, and age (Celecová et al., 2013). We have found a strong
association between TBARS and papillary bleeding index and
confirmed the results from a previous study (Celec et al., 2005).
Moreover, it was shown that this association is age independent.
Only TBARS and no other analyzed markers of oxidative stress
were associated with periodontitis (Celecová et al., 2013). When
MDA was assessed using HPLC periodontitis patients had
higher MDA in gingival crevicular fluid but not in saliva (Wei
et al., 2010). These results are in accordance with our results
showing that salivary TBARS other thanMDA are associated with
periodontitis (Celec et al., 2005). On the other hand, superoxide
dismutase and TOS levels were higher in periodontitis patients
in both, gingival crevicular fluid and saliva. In addition, 16
weeks of non-surgical treatment decreased lipid peroxidation.
Significant positive correlations were observed between clinical
indices and MDA, TOS, and superoxide dismutase levels in both
oral fluids (Wei et al., 2010). Scaling and root planing resulted
in an increase in TAC, uric acid, and glutathione peroxidase, but
also in a decrease in superoxide dismutase activity (Novakovic
et al., 2014). This finding has been further strengthened by
mass spectrometry analysis of ions in patients with periodontitis
where Cu, Zn, and Mn ions—all important for superoxide
dismutase isoforms were lower in patients vs. controls. In
line are the found higher concentrations of isoprostanes as a
consequence of lipid peroxidation (Huang et al., 2014). Several
authors have assumed that higher lipid peroxidation in saliva
is associated with increased percentage of gingival crevicular
fluid in the saliva of periodontitis patients (Akalin et al., 2007;
Su et al., 2009; Wei et al., 2010). Lipid peroxidation products
in saliva might arise from ROS/RNS production by neutrophils
activated by periodontal pathogens (Chapple and Matthews,
2007) or from direct microbial production of ROS/RNS (Vlková
and Celec, 2009). Especially DNA damage markers seem to
be associated with the presence and abundance of specific
periodontal pathogens (Almerich-Silla et al., 2015).
Salivary 8-OHdG as a marker of DNA damage was higher
in periodontitis patients in comparison to controls (Novakovic
et al., 2013) but not in gingivitis patients (Sezer et al., 2012).
Higher concentrations of salivary 8-OHdG in periodontal
diseases were found also in several other studies (Takane et al.,
2002; Sawamoto et al., 2005; Canakçi et al., 2009; Su et al.,
2009; Novakovic et al., 2013; Miricescu et al., 2014). Initial
periodontal therapy led to a decrease in salivary 8-OHdG.
Thus, 8-OHdG could become a useful biomarker for evaluating
the efficacy of periodontal treatment and individual prognosis
(Takane et al., 2002, 2005). In another study, however, these
findings could not be confirmed (Dede et al., 2013). Some studies
have found a correlation between salivary 8-OHdG and the
presence of Porphyromonas gingivalis or the large mitochondrial
DNA deletion in gingival tissues (Canakçi et al., 2009).
Oxidative damage to proteins may have dangerous
consequences in a cell due to their important catalytic functions
(Dalle-Donne et al., 2003). Protein carbonyl content is the most
widely used marker of protein oxidation (Sezer et al., 2012). It is
associated with clinical indices of oral health, especially if gender
of the patients is taken into account (Sculley and Langley-Evans,
2003). This has been confirmed in another study focusing on
the prognostic potential of specifically oxidized salivary proteins
such as transferrin, human IgG1 heavy chain fragment and
amylase (Su et al., 2009). AOPP was originally suggested as a
marker of oxidative damage in plasma of chronic uremic patients
(Witko-Sarsat et al., 1996). Only two studies coming from our
group have analyzed AOPP in saliva in relation to periodontal
status. However, we have found an association between salivary
AOPP and papillary bleeding index neither in adults (Celecová
et al., 2013) nor in children (Tóthová et al., 2013a). Oxidative
and carbonyl stress are closely linked. Reactive carbonyl groups
can non-enzymatically react with amino groups of proteins
leading to the production of AGEs. Lipid peroxidation products
including MDA possess reactive carbonyl groups and can
substitute carbohydrates in the Maillard reaction as the basis
of AGEs production (Miyata et al., 2000). Similarly to AOPP,
salivary AGEs were not associated with periodontal status in any
of the studied group of patients (Celecová et al., 2013; Tóthová
et al., 2013a).
Relatively few studies examined the concentrations of salivary
NO in patients with gingivitis or periodontitis. Most of
them observed higher NO concentrations depending on the
periodontitis severity when compared to healthy controls (Reher
et al., 2007; Parwani et al., 2012; Sundar et al., 2013; Wadhwa
et al., 2013; Poorsattar Bejeh-Mir et al., 2014), but NO was
decreased by the treatment (Parwani et al., 2012). Interestingly, in
another study nitrite concentrations were lowered by treatment
only in erythrocytes and not in plasma or saliva (Meschiari
et al., 2015). Salivary concentrations of NO can be altered by
other factors, especially smoking. Some studies, however, found
lower salivary NO in patients with periodontitis compared to
the healthy controls (Aurer et al., 2001; Andrukhov et al.,
2013). The reasons for these discrepancies might include
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differences in the analytical methods, but also in the pre-analytic
phase.
Similar reasons could explain some of the contradictory
findings on TAC (Chapple and Matthews, 2007). In most of the
studies TAC was found to be lower in patients with periodontitis
(Chapple, 1997; Diab-Ladki et al., 2003; Mashayekhi et al., 2005).
This has been confirmed by another study, while the three
main specific salivary antioxidants assessed—uric acid, ascorbic
acid, and albumin were not significantly different from controls
(Diab-Ladki et al., 2003). A study focusing on the antioxidant
melatonin found that neither plasma, nor salivary concentrations
were different between patients and controls. The difference with
lower concentrations for patients was found in the gingival tissue
showing that saliva is not representative for all analyzed markers
in the oral cavity (Balaji et al., 2015). Mashayekhi et al. have
shown that TAC depends on the clinical severity of periodontitis.
In addition, the role of cyclic nucleotides cAMP and cGMP, which
were lower in patients vs. controls was highlighted in this study
(Mashayekhi et al., 2005). Two other studies, however, found
no difference between patients and controls in salivary TAC
(Brock et al., 2004; Tóthová et al., 2013b). In contrast, higher
salivary TAC was observed in periodontitis patients in a cross-
sectional study (Su et al., 2009). Patients with periodontitis in
that study were, however, older and consumed higher amounts
of antioxidants than controls. Nevertheless, after adjusting for
age and antioxidant intake, the multivariate analysis showed
positive correlation between salivary TAC and periodontitis (Su
et al., 2009). The crucial difference might, thus, lie in the
dynamics of the disease that could differ between studies and
is rarely reported. There might be also an often overlooked
sex difference in salivary TAC being lower in women (Sculley
and Langley-Evans, 2003). Miricescu et al. have reported lower
salivary TAC and also uric acid as well as glutathione peroxidase
in whole saliva of patients with periodontitis (Novakovic
et al., 2013). In other studies lower salivary glutathione—the
main intracellular antioxidant and ceruloplasmin—an important
extracellular antioxidant were reported in periodontitis patients
in comparison to healthy probands (Tsai et al., 2005; Dalai et al.,
2013). This could be explained by a depletion of the antioxidants
due to increased ROS/RNS generation. It is unclear whether
periodontal pathogens could be directly involved (Tsai et al.,
2005). The studies on salivary oxidative stress and antioxidant
status markers in relation to periodontal disease are summarized
in Table 2.
ISSUES AND LIMITATIONS
Numerous studies summarized in this review show the potential
of salivary markers of oxidative, carbonyl stress and antioxidant
status as they seem to be associated with oral diseases, their
severity and respond to treatment (Figure 1). However, there
are several limitations that explain why these markers are not
in routine clinical use yet. From the summary tables it is clear
that the reported concentrations of the salivary markers differ
by orders of magnitude between studies. With such a variability,
contradictory results from the studies are not surprising. The
reasons for such a variability are both, technical and biological.
Various different methods and protocols for each particular assay
are used as comprehensively reviewed by others (Palmieri and
Sblendorio, 2007a; Wang et al., 2015a). Our research uncovered
several pre-analytical factors that affect the salivary markers of
oxidative stress including saliva collection, daytime, intake of
antioxidants, tooth-brushing and others (Kamodyová and Celec,
2011; Kamodyová et al., 2013). Importantly, salivation should
not be induced as such samples are biased in comparison to
spontaneous salivation. And although collection devices such as
Salivette make saliva collection even more effective, their use
should be limited to biomarkers that are resistant to such a
collection method. This is not the case for most of the studied
markers of oxidative stress. Our unpublished preliminary data
show that a major impact on the subsequent analyses can come
from such a small step as centrifugation after saliva collection.
Although our data do not support this assumption, it can be
expected that prolonged storage at different temperatures can
lead to variable results in the analysis. The stability of the
biomarkers very likely differs from marker to marker.
Beyond periodontitis and caries there are other oral and
systemic diseases that were studied in relation to salivary markers
of oxidative stress. Oral precanceroses such as lichen planus and
leukoplakia but also patients with oral squamous cell carcinoma
were found to be associated with higher MDA (Lopez-Jornet
et al., 2014; Metgud and Bajaj, 2014). In one study autistic
children had lower salivary TAC in comparison to their healthy
siblings, although this difference can be attributed to worse oral
hygiene (Rai et al., 2012). Markers of carbonyl stress such as
salivary AGEs are modified by the treatment in sleep apnea
syndrome (Celec et al., 2012). Even patients with the Down
syndrome have higher salivary MDA and superoxide dismutase
when compared with controls (de Sousa et al., 2015). It is very
likely that other physiological and pathological factors including
renal diseases, diabetes mellitus, and systemic inflammatory
disorders influence salivary concentrations of biomarkers and a
lot of research is yet to be conducted. A summary of the current
research on salivary oxidative stress markers including studies on
extra-oral or systemic diseases was published recently (Buczko
et al., 2015).
The level of evidence varies between the studies. Only few
of them report results from more than 100 patients. With
such high technical and biological variability it is clear that
the number of patients/samples has to be high to extract
meaningful information from the gathered data. The most
important limitations are, however, the unclear causality of the
observed associations. Even tight correlation do not have to be
due to a causal relationship. The causality can only be tested in
interventional experiments in animal models or human patients.
FUTURE OUTLOOK
Especially, the easy and non-invasive collection of saliva makes
it a very interesting diagnostic fluid. Although numerous pitfalls
have to be taken into account, analysis of salivary biomarkers
could make it into routine clinic when it comes to salivary
steroids, DNA, RNA, or the oral microflora. It is possible that
in the future also salivary markers of oxidative stress will be
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FIGURE 1 | Potential for non-invasive use of salivary biomarkers associated with caries and periodontitis. Saliva can be used for disease screening,
monitoring of progress, and treatment as well as in basic research on etiology or pathogenesis. 8-OHdG, 8-hydroxyguanosine; AOPP, advanced oxidation protein
products; FRAP, ferric reducing antioxidant power; NO, nitric oxide; TAC, total antioxidant capacity; TBARS/MDA, thiobarbituric acid reacting
substances/malondialdehyde; TOS, total oxidant status; SOD, superoxide dismutase.
FIGURE 2 | The origin of salivary markers of oxidative stress. Three possible sources are shown—blood plasma (A), oral bacteria (B), and immune cells (C).
Although direct evidence is lacking, salivary markers of oxidative stress seem to be of local oral origin. At least in periodontitis the production of reactive oxygen
species by oral bacteria or activated neutrophils seems to be of importance. In systemic diseases diffusion from plasma could be the main source of salivary markers
of oxidative stress.
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 18 October 2015 | Volume 5 | Article 73
Tóthová et al. Saliva and oxidative stress
used for screening and monitoring of oral diseases such as
periodontitis or caries as these markers seem to be mostly of
local oral origin (Figure 2). It should not be seen as a substitute
for proper clinical examination but rather an adjuvant tool
for various applications such monitoring of the patients with
poor adherence to dental visits. Especially, if the biochemical
detection methods will be developed into simple strips that
change color based on the concentration of the particular marker
similarly to urine strips. Such first example already exist with
a strip detecting thiol compounds known to be higher in
periodontitis patients (Khocht et al., 2013). However, before
that numerous mentioned obstacles have to be solved. Future
studies should concentrate on identification of the sources of the
observed variability, widening the palette of the available markers
and experiments proving the role of oxidative stress in the
pathogenesis of oral diseases. Inflammatory markers measured
in saliva are very informative regarding the periodontal status
of patients (Rathnayake et al., 2013; Salminen et al., 2014).
Cooperative efforts focused on large multi-centric studies with
sufficient power and standardized analysis are needed. Promising
targeted antioxidant treatments could be a way how to approach
cases of therapy-resistant periodontitis as partially shown for
melatonin (Kara et al., 2013; Arabaci et al., 2015). The potential
of non-invasive diagnosis and treatment of oral diseases makes
salivary markers of oxidative stress very attractive for further
research. And for this future a paradigm shift will be needed as
the research will very likely by dominated by high-throughput
approaches such as salivary metabolome analysis (Dame et al.,
2015).
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